https://www.thebodypro.com/category/first-line-hiv-treatment/tag/international-aids-conference
First-Line HIV Treatment

International AIDS Conference

The Latest

Test and Treat Did Not Impact Transmission Rates in South African Study Img

Test and Treat Did Not Impact Transmission Rates in South African Study

On behalf of IFARA, Fred Schaich spoke with François Dabis, M.D., Ph.D., about a study presented at this year's International AIDS Conference on the impact of the "test and treat" strategy on HIV transmission rates.

Excellent Uptake of Test and Treat in Swaziland Pilot Project Img

Excellent Uptake of Test and Treat in Swaziland Pilot Project

The results of a "test and treat" pilot project in Swaziland presented at this year's International AIDS Conference were very positive, with a very high uptake of testing and starting treatment, good retention in care and good viral suppression.

Early HIV Treatment Lowers Transmission Risk by Up to 93%: HPTN 052 Final Results Img

Early HIV Treatment Lowers Transmission Risk by Up to 93%: HPTN 052 Final Results

Final results of HPTN 052, the watershed randomized trial that positioned antiretroviral therapy (ART) as an HIV prevention strategy, indicate that participants starting ART at a high CD4 count sustained a 93% lower risk of transmitting HIV to sex pa...

Promo Image

Study Cites Benefits of Early AIDS Treatment

Starting antiretroviral therapy (ART) earlier rather than later is cost-effective and helps prevent AIDS-related illnesses, according to two studies presented at the 19th International AIDS Conference in Washington. The studies add to a body of evide...

Promo Image

Expanded Analysis of HPTN 052 Study Results Reveal Additional Benefits of Early HIV Treatment

Study results released today by the HIV Prevention Trials Network (HPTN) show additional benefits of early antiretroviral therapy (ART) in HIV clinical outcomes. Expanded analysis of HPTN 052 study data, presented today at the XIX International AIDS ...

Promo Image

Starting HAART: When to Take the First Step?

Transcript (.pdf)

For more information on this session, including access to speaker presentations, please see the conference Programme-at-a-Glance.

Recent guidelines are all recommending that HIV treatment be started at a higher CD4 count because o...

Promo Image

HIV Drugs Should Be Initiated Earlier, Says UN

All HIV-positive people with a CD4+ T-cell count of 350 cells/mm3 or lower should begin antiretroviral therapy (ART), the World Health Organization said on Monday. WHO released the first revision to its ART recommendations in four years at the 18th I...

Promo Image

Earlier Treatment of HIV Could Help HIV-Positive People Avoid Long-Term Complications, Recommendations Say

A panel of the International AIDS Society-USA in the Aug. 6 issue of the Journal of the American Medical Association issued new recommendations for when doctors should begin antiretroviral treatment for patients with HIV, AFP/Google.com reports. The ...

Promo Image

Efavirenz-Based Regimens Best Lopinavir/Ritonavir Regimens in Head-to-Head Trial

Traditionally, an antiretroviral therapy regimen has consisted of two nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) plus a third drug, either a protease inhibitor (PI) or a non-nucleoside reverse transcriptase inhibitor (NNRTI). The ...

Promo Image

SMART & Staccato: Two CD4-Guided Treatment Interruption Trials With Contradictory Results

Introduction

While the value of highly active antiretroviral therapy (HAART) for the management of HIV infection and AIDS has been proven in many clinical trials in all parts of the world, one of the most basic strategic questions of HIV management ...